Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

Chronos Therapeutics Announces Positive Pre-Clinical Proof of Concept Studies for its Orexin-1 Antagonist Project Initially Targeting Binge Eating Disorder

Chronos Therapeutics Ltd (Chronos) the private biotech company focused on ageing diseases, brain and nervous system disorders, announced today that the lead compound in its addiction programme, CT-010018 an orexin-1 antagonist, demonstrated positive pre-clinical proof of concept (POC) results in an in vivo model of binge eating disorder (BED).

Read the rest of entry »

Oxford Expression Technologies is Awarded £2 Million Vaccine Development Contract

Oxford Expression Technologies Ltd (OET) is pleased to announce that it has been awarded a £2M contract from Innovate UK to continue its ongoing work in developing the first economically viable vaccine against Crimean Congo Haemorrhagic Fever (CCHF) virus.

Read the rest of entry »

 Business Development Manager (Energy)

Do you have experience of selling energy procurement contracts into the I&C retail UK Energy Industry? A leading Gas and Electricity consultants is seeking a Business Development Manager to join their Coventry based team, to enhance the company’s position in terms of both new sales and margin growth

Read the rest of entry »

Mologic Signs Agreements with Medisur and Peripal to Distribute PERIPLEX POC Diagnostic in Europe

Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has signed agreements with medical technology companies, Medisur and Peripal AG to distribute PERiPLEX®

Read the rest of entry »

Isogenic Cell Lines for Cancer Research

AMSBIO has introduced a new range of over 400 Isogenic cell lines that provide a reliable and efficient alternative to traditional human disease models.

Read the rest of entry »

Crescendo raises $70M to trial bispecific T-cell engager

Crescendo Biologics has raised $70 million (€57 million) to take its lead bispecific T-cell engager into the clinic. The financing equips Crescendo to show whether its vision for dialing up T-cell activity in the tumor microenvironment translates into humans.

Read the rest of entry »

Congratulations to Public Health England (PHE) for winning the British Expertise International Awards 2018

Congratulations to Public Health England (PHE) for winning the British Expertise International Awards 2018 under “international healthcare project” category for “Fast-track global collaborations to conquer emergencies such as Ebola and Zika”.  PHE’s Senior Business Development Manager Professor S.S. Vasan collected the award on his team’s behalf from HRH The Duke of Gloucester KG GCVO on 12 April 2018. Thanking his colleagues “who have made such a difference to our response to Ebola and Zika crises”, Professor Vasan said, “The aspect of our project we are most proud of is collaborations. It is absolutely essential when you are facing a global emergency like Ebola or Zika that we set aside differences, and we keep the focus on saving lives and working in collaboration with industry, academia and non-profit sector so that the response can be very effective and very quick. Every minute saves lives, literally, in this case.”      & ...

Read the rest of entry »

OBN concludes hugely successful BioTrinity 2018 conference

Leading annual life sciences event attracted more than 160 company CEOs, in excess of 150 leading investors and over 80 major pharmaceutical company delegates

Read the rest of entry »

Driven by rapid growth Oxford Sciences Innovation expands to The Oxford Science Park

OSI builds on links with Park as second occupier of prestigious Schrödinger Building

Read the rest of entry »

PATH and Mologic advance new malaria test

Seattle, Washington, April 17, 2018—PATH and United Kingdom-based test developer Mologic have entered an agreement to advance a new rapid diagnostic test to support treatment and elimination of Plasmodium vivax, or relapsing, malaria.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.